Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE studyGuy Young, Robert Klamroth, Tadashi Matsushita et al.|Blood|2025Cited by 38
Efficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)Guy Young, Savita Rangarajan, Alok Srivastava et al.|Blood|2021Cited by 16
The Clinical Implications of ADAMTS13 Function: The Perspectives of HaemostaseologistsSavita Rangarajan, Louis M. Aledort, Craig M. Kessler|Thrombosis Research|2013Cited by 4